A new study looks at how blood signatures in menopausal women predict their dementia risk.

A new clinical trial will screen for atrial fibrillation (AFib) using a blood pressure monitor with AFib detection technology with the goal to decrease time to AFib diagnosis in patients with high blood pressure. The randomized trial will compare this monitor to usual care using a conventional home blood pressure monitor with no AFib detection.

UCSF scientists helped transform KRAS, once considered an “undruggable” cancer target, into a pathway for life-saving treatments. Discover how Kevan Shokat, PhD, and colleagues found a hidden pocket in the cancer-driving protein, paving the way for a new generation of targeted cancer therapies.

Former UCSF Chancellor and Nobel laureate J. Michael Bishop, MD, who passed away this year, helped transform modern cancer research and established UCSF as a global leader in scientific discovery. We reflect on his legacy through memorable pieces of advice on science, creativity, discovery, the Nobel Prize, and the vital role of federal research funding — highlighting the enduring impact of his ideas and UCSF's remarkable Nobel legacy.

A new AI-based model can predict where the most common malignant brain cancer is most likely to return after initial surgery, potentially giving doctors a chance to treat it before it becomes visible on MRI.

Kevan Shokat, PhD, a professor of Cellular and Molecular Pharmacology at UC San Francisco who discovered how to disable KRAS, a seemingly unstoppable cancer-driving protein, has won the Stephenson Global Prize for research in pancreatic cancer.

Clinicians and researchers set to gather for the UCSF-cosponsored international invasive lobular carcinoma symposium in San Francisco, Sept. 23 to 25.